{"database": "openregs", "table": "documents", "rows": [["FDA-2024-D-2033-0002", "FDA", "FDA-2024-D-2033", "Expedited Program for Serious Conditions\u2014Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry", "Other", "Guidance", "2024-12-06T05:00:00Z", 2024, 12, "2024-12-06T05:00:00Z", "2025-03-07T04:59:59Z", "2025-07-16T09:00:27Z", null, 1, 0, "090000648684bb37"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2024-D-2033-0002"], "units": {}, "query_ms": 102.23812004551291, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}